Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Oct 15 (Reuters) — SciBase Holding AB (publ): Scibase's Electrical Impedance Spectroscopy (Eis) Technology Selected As Primary Endpoint In National Institute Of Health (Nih) Skin Barrier Study Source text:... Further company coverage: SCIB.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;)
SciBase says its EIS technology was selected as the primary endpoint for a new study involving the NIH and the Swiss Institute.
SciBase’s Nevisense device was selected as the primary endpoint measurement tool for the NIH-led THREAT study of environmental exposure effects on skin. The planned study involves 80 healthy volunteers in collaboration with the Swiss Institute of Allergy and Asthma Research. Researchers will assess how everyday product